Eribulin Mesylate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.44 mg/mL
Reference Brands: HALAVEN (USA/EU)
Category: Oncology Cancer Care
Eribulin mesylate is a microtubule dynamics inhibitor derived from the marine sponge Halichondria okadai. It is used for the treatment of patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. The drug works by inhibiting microtubule growth, leading to cancer cell cycle arrest and apoptosis. Halaven is administered intravenously under medical supervision and is recognized for extending survival in patients with advanced cancer. Eribulin mesylate is available in Injection and strengths such as 0.44 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Eribulin mesylate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Eribulin mesylate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eribulin mesylate is used to treat patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. It works by inhibiting microtubule dynamics in cancer cells, which leads to cell cycle arrest and apoptosis, helping to slow or stop tumor growth.
Eribulin mesylate is made from a synthetic analog of halichondrin B, a compound originally derived from the marine sponge Halichondria okadai. It is a microtubule dynamics inhibitor that targets cancer cells.
The trade name of Eribulin mesylate is Halaven.
Eribulin mesylate (Halaven) is manufactured by Eisai Co., Ltd. and marketed globally in collaboration with other licensed pharmaceutical distributors.
The generic name of Eribulin mesylate is Eribulin mesylate.
The brand name of Eribulin mesylate is Halaven.
Eribulin mesylate is manufactured in Japan and other countries by Eisai Co., Ltd. under strict GMP-certified conditions for oncology therapeutics.
Related Products
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
